At two weeks after stroke, FGF-21 levels were significantly decreased in both non-T2D and T2D-VH mice (Fig. 3a) and remained significantly lower than pre-stroke levels in T2D-VH (p = 0.01) at five weeks post-stroke (Fig. 3a). This evidence concerns the gene FGF21 and type 2 diabetes mellitus.